Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Treatment
Teatment with aromatase inhibitors may significantly impact healthcare costs
October 20th, 2005
Teatment of postmenopausal women with breast cancer with aromatase inhibitors may significantly impact healthcare costs. "Novel, third-generation aromatase inhibitors are currently implemented for treatment of postmenopausal breast cancer in the metastatic and adjuvant setting and, potentially, for breast cancer prevention," researchers in Norway report. "Introduction of novel therapeutic strategies to large patient groups may add significant costs to health care budgets, forcing institutions to focus entirely on costs or the cost-utility of implementing such novel strategies." "Breast cancer is the most frequent cancer in the female population in...
Source: Women's Health Weekly (2005-10-20)
|
